55
Avenzo Therapeutics, Inc. raises $47.2M under Reg D
Company raise · Raising · Offering $75M · Sold $47.2M · SAN DIEGO, CA · filed 2025-09-05
35
Avenzo Therapeutics, Inc. files Form D
Company raise update · Closed · SAN DIEGO, CA · Form D/A filed 2024-11-20
$50M+ raise
Why now — by persona
Relevant to: B2B software & services sales. Lead card pending.
People on the filing
| Athena Countouriotis | Executive Officer, Director |
| Carl Gordon | Director |
| Judith Li | Director |
| Scott Lipman | Executive Officer |
| Mohammad Hirmand | Executive Officer |
| Jakob Dupont, M.D., M.A. | Director |
| Garry Nicholson | Director |
| Brian Sun | Executive Officer |
| Paolo Tombesi | Executive Officer |
| Simeon George | Director |
Signed by Athena Countouriotis, M.D., Chief Executive Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.